Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This intervention is a combination of the amide-type local anesthetic **bupivacaine** and the synthetic glucocorticoid **dexamethasone**, specifically evaluated as a perineural adjuvant in regional anesthesia. In clinical practice, particularly for shoulder surgeries, dexamethasone is added to local anesthetics like bupivacaine for interscalene nerve blocks to significantly prolong the duration of sensory and motor blockade and improve postoperative analgesia. The clinical trial context provided by **Lifespan** (NCT02343315) specifically investigates the systemic metabolic impact of this combination, hypothesizing that the 8 mg dose of dexamethasone used as an adjuvant does not cause a significant increase in plasma glucose levels in non-diabetic patients undergoing shoulder surgery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bupivacaine + dexamethasone (Lifespan Biotech).